It is a pharma private limited company based in Kukatpally, Telangana, India, established in 2020.
2020 | Kukatpally, Telangana, India | ActiveViplus Pharmaceuticals Private Limited, a active private limited company, was established on 03 November 2020 in Kukatpally, Telangana, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24299TG2020PTC145526. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹4.01 Cr and a paid-up capital of ₹2.01 Cr.
Its leadership includes Prakash Reddy Vinta (Director), Satwick Reddy Vinta (Director), Sashank Reddy Vinta (Director). Past directors included Satwick Reddy Vinta. It holds ₹30.60 Cr open charges and ₹15.00 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Flat No. 104, Block No.2, Hydernagar Village, Kukatpally, Telangana, 500085.
U24299TG2020PTC145526
145526
03 November 2020
₹4.01 Cr
₹2.01 Cr
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Viplus Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Prakash Reddy Vinta | Director | 03 Nov 2020 | Current |
| Satwick Reddy Vinta | Director | 03 Nov 2022 | Current |
| Sashank Reddy Vinta | Director | 03 Nov 2020 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 29 Sep 2023 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Viplus Pharmaceuticals Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 83.4% increase. The company also saw a substantial improvement in profitability, with a 588.57% increase in profit. The company's net worth Soared by an impressive increase of 261.9%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Viplus Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹306,000,000.00
₹150,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 04 Aug 2023 | Axis Bank Limited | ₹29.95 Cr | Open |
| 29 Jun 2023 | Others | ₹6.50 M | Open |
| 31 Jan 2022 | Others | ₹15.00 Cr | Satisfied |
Explore comprehensive loan charge details -
Viplus Pharmaceuticals has a workforce of 0 employees as of Sep 25, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Viplus Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Viplus Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on A charge with Axis Bank Limited of Rs. 29.95 Cr registered on 04 Aug 2023 with Charge ID 100769128 was modified on 20 Feb 2025. was documented.
Viplus Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Progress on Viplus Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was documented.
A charge registered on 31 Jan 2022 via Charge ID 100537810 with Others was fully satisfied on 16 Oct 2023. was recorded as a recent event.
Progress on A charge with Axis Bank Limited amounted to Rs. 29.95 Cr with Charge ID 100769128 was registered on 04 Aug 2023. was documented.
A charge with Others amounted to Rs. 0.65 Cr with Charge ID 100748006 was registered on 29 Jun 2023. was recorded as a recent event.
The CIN of Viplus Pharmaceuticals Private Limited is U24299TG2020PTC145526.
Viplus Pharmaceuticals Private Limited is headquartered at Flat No. 104, Block No.2, Hydernagar Village, Kukatpally, Telangana, 500085.
Viplus Pharmaceuticals Private Limited was incorporated on 03 November 2020.
The current directors of Viplus Pharmaceuticals Private Limited are
The primary industry of Viplus Pharmaceuticals Private Limited is Trade.
Viplus Pharmaceuticals Private Limited is unlisted.
The authorized capital of Viplus Pharmaceuticals Private Limited is ₹4.01 Cr, and the paid-up capital is ₹2.01 Cr.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX